Sheldon Whitehouse's AMGN trades

  • The latest AMGN trade was a sale on Oct 15, 2026, when AMGN closed at $434.03. It closed at $435.64 on Nov 20, 2026 (flat).

Price changes use the closing price on each trade date, not the price actually paid, and ignore dividends. Filings report amounts only as ranges, so these figures show direction, not anyone's actual profit.

Sheldon Whitehouse reported 3 AMGN transactions in 3 filings with the Senate eFD for 2025–2026: 0 purchases and 3 sales of Amgen Inc., with trade dates from Sep 4, 2025 to Oct 15, 2026. The median gap between trade date and filing date is 21 days, and every trade was reported within 45 days.

Transactions
3
Buys / sells
0 / 3
Disclosed range
$17K to $80K
Last filed
2026-11-02

AMGN transactions reported by Sheldon Whitehouse

3 of 3 rows
TypeOwner
Amgen Inc. - Common Stock
AMGN
SaleSpouse$15,001 - $50,0002026-11-02
#02b5fe88-e8e1-4ef3-b6b5-6a46b420fb3c
Amgen Inc. - Common Stock
AMGN
SaleSpouse$1,001 - $15,0002026-09-02
#f8d003c0-ca1e-4c39-9d66-632d220180e1
Amgen Inc
AMGN
SaleSelf$1,001 - $15,0002025-10-03
#12bfb6c8-5dbf-4f2a-994b-c936a0a0a91d

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

How long disclosure took

Days from trade date to filing date for 3 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.

0–15 days
0
16–30 days
3
31–45 days
0
Over 45 days
0
Median / longest
21d / 29d

Source documents

3 Senate eFD periodic transaction reports, newest first. Each link opens the official filing.

What Sheldon Whitehouse's AMGN filings don’t tell you

A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.

To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.

Members-only research

What members are reading this month

The thesis, the numbers behind it, and what would break it. Full access is $39 a month.

Read the full research

Sheldon Whitehouse and AMGN: questions

Did Sheldon Whitehouse buy or sell AMGN?

Senate eFD filings for 2025 and 2026 show 0 purchases and 3 sales of Amgen Inc. (AMGN) reported by Sheldon Whitehouse, between 2025-09-04 and 2026-10-15. Reported owners: Spouse, Self.

How much AMGN did Sheldon Whitehouse trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $17K to $80K across 3 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last AMGN filing by Sheldon Whitehouse?

The most recent filing that includes a AMGN trade was filed on 2026-11-02. New filings appear in the Senate eFD index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with Amgen Inc.. Rows are parsed from public Senate eFD periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

Sheldon Whitehouse AMGN disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $39/month or $249/year.

$39/mo or $249/yr · cancel future renewals anytime · sources included